Efficient Treg depletion induces T-cell infiltration and rejection of large tumors.
作者： Xingrui Li , Efterpi Kostareli , Janine Suffner , Natalio Garbi , Günter J. Hämmerling
关键词:
摘要: … Therefore, it is possible that the normalization observed after extensive Treg depletion may also facilitate infiltration. The increased expression of the adhesion molecules VCAM-1 and …
sci-hub.se 参考文章(47)
Shari Pilon-Thomas, Amy Mackay, Nasreen Vohra, James J. Mulé, Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma Journal of Immunology. ,vol. 184, pp. 3442- 3449 ,(2010) , 10.4049/JIMMUNOL.0904114
Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication Cancer Research. ,vol. 62, pp. 1462- 1470 ,(2002) , 10.1078/0171-2985-00078
Natalio Garbi, Bernd Arnold, Siamon Gordon, Günter J. Hämmerling, Ruth Ganss, CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction The Journal of Immunology. ,vol. 172, pp. 5861- 5869 ,(2004) , 10.4049/JIMMUNOL.172.10.5861
Gang Zhou, Hyam I. Levitsky, Natural Regulatory T Cells and De Novo-Induced Regulatory T Cells Contribute Independently to Tumor-Specific Tolerance Journal of Immunology. ,vol. 178, pp. 2155- 2162 ,(2007) , 10.4049/JIMMUNOL.178.4.2155
Suigui Wan, Changqing Xia, Laurence Morel, IL-6 Produced by Dendritic Cells from Lupus-Prone Mice Inhibits CD4+CD25+ T Cell Regulatory Functions Journal of Immunology. ,vol. 178, pp. 271- 279 ,(2007) , 10.4049/JIMMUNOL.178.1.271
Karsten Mahnke, Kurt Schönfeld, Sabine Fondel, Sabine Ring, Svetlana Karakhanova, Katharina Wiedemeyer, Tanja Bedke, Theron Scott Johnson, Volker Storn, Sonja Schallenberg, Alexander Herrmann Enk, Depletion of CD4+CD25+ human regulatory T cells in vivo: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro International Journal of Cancer. ,vol. 120, pp. 2723- 2733 ,(2007) , 10.1002/IJC.22617
Thomas A. Waldmann, Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey. Journal of Clinical Immunology. ,vol. 27, pp. 1- 18 ,(2007) , 10.1007/S10875-006-9060-0
Daniel J. Powell, Peter Attia, Victor Ghetie, John Schindler, Ellen S. Vitetta, Steven A. Rosenberg, Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration. Journal of Immunotherapy. ,vol. 31, pp. 189- 198 ,(2008) , 10.1097/CJI.0B013E31815DC0E8
Tewfik Miloud, Carmen Henrich, Günter J. Hämmerling, Quantitative comparison of click beetle and firefly luciferases for in vivo bioluminescence imaging. Journal of Biomedical Optics. ,vol. 12, pp. 054018- ,(2007) , 10.1117/1.2800386
J. W. Rose, J. B. Burns, J. Bjorklund, J. Klein, H. E. Watt, N. G. Carlson, Daclizumab phase II trial in relapsing and remitting multiple sclerosis MRI and clinical results Neurology. ,vol. 69, pp. 785- 789 ,(2007) , 10.1212/01.WNL.0000267662.41734.1F